Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

First patients are treated with Siemens new linear accelerator for Adaptive Radiation Therapy

Siemens Healthcare USA : 20 June, 2008  (Company News)
The Artiste Solution from Siemens has recently been used for treatment in three of the most prominent cancer centres around the world.
Dozens of patients have been treated to date at MAASTRO Clinic in the Netherlands, German Cancer Research Center (DKFZ) in Heidelberg, Germany, and Baton Rouge General’s Pennington Cancer Center in Louisiana.

The Artiste Solution is a linear accelerator engineered specifically for Adaptive Radiation Therapy (ART). The Artiste is an integrated imaging and workflow solution that offers a comprehensive portfolio of image-guided and advanced treatment delivery protocols, including in-room CT imaging capabilities and a new multileaf collimator, 160 MLC.

One of the first patients treated with Artiste was seen at DKFZ, where the linear accelerator was used to administer Radiotherapy for an inoperable oesophagus tumour.

“Treatment for this type of tumor demands a very complicated Radiotherapy approach,” said Prof Dr Huber, head of the Radiation Oncology Clinical Cooperation Unit at DKFZ. “Using Artiste’s 160 MLC Multileaf Collimator, we were able to significantly improve the precision of the dose delivery while protecting immediate surrounding healthy tissue.”

In the same same week, several patients at MAASTRO Clinic were also treated using Artiste. A couple of challenging clinical cases included a metastasized tumour in the abdominal region and a patient with two separate metastases: one in the head and neck region, and one in the knee cap.

“The advanced, high-end imaging capabilities of Artiste allow us to fully integrate all our Image-guided radiation therapy (IGRT) and MAASTRO-developed Dose-Guided Radiation Therapy (DGRT) methods in one clinical workflow. Artiste’s imaging flexibility and simplified workflow help us to confidently treat proliferated tumors in a wide range of areas of the body,” said Bas Nijsten, medical Radiotherapy physicist in the Maastricht Radiation Oncology Department.

More recently, the first US patients were treated with Artiste Solution at the Baton Rouge General’s Pennington Cancer Center. The first two patients were treated for lung and prostate tumours, respectively, where Artiste’s 2D and 3D imaging allowed confirmation of tumor location and enabled more focused and aggressive treatment while helping spare organs at risk.

“With Artiste, Siemens is changing the way Radiotherapy is delivered. As the first site in the US with Artiste, our mission at Baton Rouge General’s Pennington Cancer Center is to combine our commitment to compassionate cancer care with the latest, most advanced treatment technology,” said Dr William Russell, medical director of Radiation Oncology at Pennington Cancer Center.

“This exciting milestone has come to fruition thanks to the clinical collaboration between Siemens, MAASTRO, DKFZ, and Baton Rouge General,” said Holger Schmidt, chief executive officer, Oncology Care Systems, Siemens Medical Solutions USA. “Artiste’s unique integration of technologies and streamlined workflow allows clinicians to truly customise patient treatment by providing them the flexibility and means to confidently optimise treatment on a per-patient basis. It is an honor for us at Siemens to be part of this collaborative effort to help improve quality of care for cancer patients around the world. We are delighted to call 55 new Artiste orders since its introduction in the market last January.”

The goal of Adaptive Radiation Therapy (ART) is to ensure the therapeutic dose is delivered precisely to the target, and healthy tissue is spared as planned. To achieve this goal, it is necessary to image the patient just prior to treatment, verify that the patient position is correct, and adapt to any anatomical changes immediately before, or even during, treatment.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo